Celldex Therapeutics, Inc. (FRA:TCE2)
Germany · Delayed Price · Currency is EUR 23.00
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:19 AM CET
Celldex Therapeutics Market Cap
Celldex Therapeutics has a market cap or net worth of €1.48 billion as of December 1, 2025. Its market cap has decreased by -12.28% in one year.
Market Cap
1.48B
Enterprise Value
982.15M
Revenue
2.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€23.00
Market Cap Chart
Since March 10, 2008, Celldex Therapeutics's market cap has increased from 74.63M to 1.48B, an increase of 1,885.31%. That is a compound annual growth rate of 18.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.55B | -4.38% |
| Dec 31, 2024 | 1.62B | -17.48% |
| Dec 29, 2023 | 1.96B | -0.10% |
| Dec 30, 2022 | 1.96B | 23.89% |
| Dec 31, 2021 | 1.59B | 179.77% |
| Dec 31, 2020 | 566.71M | 1,606.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |